These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26484434)

  • 1. Proteomics and drug discovery in cancer.
    Dias MH; Kitano ES; Zelanis A; Iwai LK
    Drug Discov Today; 2016 Feb; 21(2):264-77. PubMed ID: 26484434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into cancer drug resistance from a proteomics perspective.
    An Y; Zhou L; Huang Z; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2019 May; 16(5):413-429. PubMed ID: 30925852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteogenomics for understanding oncology: recent advances and future prospects.
    Subbannayya Y; Pinto SM; Gowda H; Prasad TS
    Expert Rev Proteomics; 2016; 13(3):297-308. PubMed ID: 26697917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical proteomics and breast cancer.
    Zeidan BA; Townsend PA; Garbis SD; Copson E; Cutress RI
    Surgeon; 2015 Oct; 13(5):271-8. PubMed ID: 25736469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer proteomics: developments in technology, clinical use and commercialization.
    Yeat NC; Lin C; Sager M; Lin J
    Expert Rev Proteomics; 2015 Aug; 12(4):391-405. PubMed ID: 26145529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics in cancer biomarkers discovery: challenges and applications.
    Sallam RM
    Dis Markers; 2015; 2015():321370. PubMed ID: 25999657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncoproteomics.
    Joshi S; Tiwari AK; Mondal B; Sharma A
    Clin Chim Acta; 2011 Jan; 412(3-4):217-26. PubMed ID: 20955692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
    Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics in cancer research: Are we ready for clinical practice?
    Maes E; Mertens I; Valkenborg D; Pauwels P; Rolfo C; Baggerman G
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):437-48. PubMed ID: 26277237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative oncoproteomics strategies for anticancer drug discovery.
    Liu R; Wang K; Yuan K; Wei Y; Huang C
    Expert Rev Proteomics; 2010 Jun; 7(3):411-29. PubMed ID: 20536311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical proteomic strategies for the discovery and development of anticancer drugs.
    Liu Y; Guo M
    Proteomics; 2014 Mar; 14(4-5):399-411. PubMed ID: 24323546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mining the Human Proteome: Biomarker Discovery for Human Cancer and Metastases.
    Yang J; Roy R; Jedinak A; Moses MA
    Cancer J; 2015; 21(4):327-36. PubMed ID: 26222086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics for identifying mechanisms and biomarkers of drug resistance in cancer.
    Li XH; Li C; Xiao ZQ
    J Proteomics; 2011 Nov; 74(12):2642-9. PubMed ID: 21964283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
    Shukla HD; Mahmood J; Vujaskovic Z
    Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemical proteomics and discovery of drug targets].
    Yang HQ; Li XJ
    Yao Xue Xue Bao; 2011 Aug; 46(8):877-82. PubMed ID: 22007509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in cancer research and multifaceted approaches for cancer biomarker quest.
    Martinkova J; Gadher SJ; Hajduch M; Kovarova H
    FEBS Lett; 2009 Jun; 583(11):1772-84. PubMed ID: 19327356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of proteomics for cancer research: past, present, and future.
    Karimi P; Shahrokni A; Ranjbar MR
    Asian Pac J Cancer Prev; 2014; 15(6):2433-8. PubMed ID: 24761843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
    Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
    Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.